Loading...
Integral Diagnostics Limited
IDX.AX•ASX
HealthcareMedical - Diagnostics & Research
A$2.32
A$-0.02(-0.85%)
Integral Diagnostics Limited (IDX.AX) Financial Performance & Statements
Review Integral Diagnostics Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.73%
↑ 6.73%
Operating Income Growth
-86.63%
↓ 86.63%
Net Income Growth
-342.41%
↓ 342.41%
Operating Cash Flow Growth
-7.36%
↓ 7.36%
Operating Margin
15.79%
↑ 15.79%
Gross Margin
26.61%
↑ 26.61%
Net Profit Margin
1.15%
↑ 1.15%
ROE
1.14%
↑ 1.14%
ROIC
6.36%
↑ 6.36%
Integral Diagnostics Limited (IDX.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Integral Diagnostics Limited stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $238.44M | $231.25M | $224.40M | $215.70M |
| Cost of Revenue | $185.56M | $180.10M | $173.84M | $168.50M |
| Gross Profit | $52.89M | $51.15M | $50.55M | $47.21M |
| Gross Profit Ratio | $0.22 | $0.22 | $0.23 | $0.22 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $30.63M | $31.24M | $28.76M | $29.55M |
| Operating Expenses | $30.15M | $30.86M | $27.89M | $29.30M |
| Total Costs & Expenses | $215.70M | $210.96M | $201.73M | $197.80M |
| Interest Income | $0.00 | $11.04M | $9.55M | $8.32M |
| Interest Expense | $11.13M | $11.42M | $9.80M | $8.56M |
| Depreciation & Amortization | $24.02M | $22.85M | $22.12M | $21.37M |
| EBITDA | $43.78M | -$31.44M | $44.19M | $48.62M |
| EBITDA Ratio | $0.18 | $0.19 | $0.20 | $0.18 |
| Operating Income | $22.74M | $20.29M | $22.66M | $17.90M |
| Operating Income Ratio | $0.10 | $0.09 | $0.10 | $0.08 |
| Other Income/Expenses (Net) | -$14.11M | -$86.00M | -$10.40M | $789970.00 |
| Income Before Tax | $8.63M | -$65.71M | $12.27M | $18.69M |
| Income Before Tax Ratio | $0.04 | -$0.28 | $0.05 | $0.09 |
| Income Tax Expense | $2.58M | $989000.00 | $3.25M | $2.35M |
| Net Income | $6.06M | -$66.76M | $8.90M | $16.14M |
| Net Income Ratio | $0.03 | -$0.29 | $0.04 | $0.07 |
| EPS | $0.03 | -$0.29 | $0.04 | $0.07 |
| Diluted EPS | $0.03 | -$0.29 | $0.04 | $0.07 |
| Weighted Avg Shares Outstanding | $233.92M | $233.25M | $233.03M | $232.52M |
| Weighted Avg Shares Outstanding (Diluted) | $233.92M | $233.25M | $236.19M | $235.58M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan